Eric D. Shaff - CEO and President, Director at Seres Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director
Stock Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Eric D. Shaff - trading volume in the past year for Seres Therapeutics, Inc.

Holdings reported by Eric D. Shaff for Seres Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 146K $123K $0.84 Aug 16, 2024 Direct
Restricted Stock Units 78.1K $65.6K $0.84 Aug 15, 2024 Direct Common Stock
Stock Option (Right to Buy) 823K Feb 14, 2024 Direct Common Stock

Transactions reported by Eric D. Shaff for Seres Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.